Isabelle Walter

743 total citations
17 papers, 574 citations indexed

About

Isabelle Walter is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Isabelle Walter has authored 17 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Isabelle Walter's work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Isabelle Walter is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Isabelle Walter collaborates with scholars based in Switzerland, Sweden and Germany. Isabelle Walter's co-authors include Beate Bittner, Jörg Huwyler, Matthias Wittwer, Carina Cantrill, Prasoon Chaturvedi, Caroline Rynn, Michael Schleimer, Christoph Funk, Franziska Boess and Neil Parrott and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Isabelle Walter

15 papers receiving 555 citations

Peers

Isabelle Walter

ONCOL

PHARM

PPCH

Katrijn Bogman Switzerland

Donato Teutonico France

Cécile Arellano France

Noriko Katori Japan

Weili Huang China

Andrés Olivares‐Morales Switzerland

Frank W. Lee United States

Heleen A. Bardelmeijer Netherlands

Tom De Bruyn Belgium

Kenji Tabata Japan

Katrijn Bogman Switzerland

Isabelle Walter

317 ×1.4

ONCOL

192 ×0.9

132 ×0.8

PHARM

145 ×1.2

79 ×0.9

PPCH

Citations per year, relative to Isabelle Walter Isabelle Walter (= 1×) peers Katrijn Bogman

Countries citing papers authored by Isabelle Walter

Since Specialization

Citations

This map shows the geographic impact of Isabelle Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Walter more than expected).

Fields of papers citing papers by Isabelle Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Walter. The network helps show where Isabelle Walter may publish in the future.

Co-authorship network of co-authors of Isabelle Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Walter. A scholar is included among the top collaborators of Isabelle Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Walter. Isabelle Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Umehara, Kenichi, et al.. (2025). Prediction of hepatic metabolic clearance in rats and dogs using long-term cocultured hepatocytes. Drug Metabolism and Disposition. 53(4). 100055–100055.

Walter, Isabelle, et al.. (2024). Attachment-based Prevention Program Involving Mothers and Fathers: Seven-year Post-Intervention Outcomes of a Randomized Control Trial. Journal of Child and Family Studies. 33(2). 538–553.

Walter, Isabelle, et al.. (2022). Estimation of Fraction Metabolized by Cytochrome P450 Enzymes Using Long-Term Cocultured Human Hepatocytes. Drug Metabolism and Disposition. 50(5). 566–575. 16 indexed citations

Cantrill, Carina, et al.. (2020). Fundamental aspects of DMPK optimization of targeted protein degraders. Drug Discovery Today. 25(6). 969–982. 116 indexed citations

Ballard, T. Eric, et al.. (2020). Simplifying the Execution of HepatoPac MetID Experiments: Metabolite Profile and Intrinsic Clearance Comparisons. Drug Metabolism and Disposition. 48(9). 804–810. 8 indexed citations

Umehara, Kenichi, et al.. (2020). In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes. The AAPS Journal. 22(6). 131–131. 23 indexed citations

Kristoffersson, Anders, Caterina Bissantz, Andreas Haldimann, et al.. (2019). A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 75(2). 400–408. 16 indexed citations

Kratochwil, Nicole A., Christophe Meille, Stephen Fowler, et al.. (2017). Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling. The AAPS Journal. 19(2). 534–550. 88 indexed citations

Meille, Christophe, Stefan Kustermann, Isabelle Walter, et al.. (2015). Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis. Journal of Pharmacokinetics and Pharmacodynamics. 42(3). 275–285. 2 indexed citations

10.

Juillerat‐Jeanneret, Lucienne, Alexander Flohr, Manfred Schneider, et al.. (2015). Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases. Journal of Medicinal Chemistry. 58(20). 8097–8109. 13 indexed citations

11.

Poirier, Agnès, Renée Portmann, Isabelle Walter, et al.. (2014). Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo. Drug Metabolism and Disposition. 42(9). 1411–1422. 37 indexed citations

12.

Poirier, Agnès, et al.. (2014). The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?. Drug Metabolism and Disposition. 42(9). 1466–1477. 36 indexed citations

13.

Bittner, Beate, et al.. (2005). Impact of Oral Administration of the Surface-Active Excipient Solutol HS 15 on the Pharmacokinetics of Intravenously Administered Colchicine. Letters in Drug Design & Discovery. 2(3). 193–195. 5 indexed citations

14.

Huwyler, Jörg, et al.. (2004). In vitro investigation on the impact of the surface‐active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharmaceutics & Drug Disposition. 25(1). 37–49. 70 indexed citations

15.

Bittner, Beate, et al.. (2003). Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharmaceutics & Drug Disposition. 24(4). 173–181. 29 indexed citations

16.

Huwyler, Jörg, et al.. (2002). Improved oral bioavailability of cyclosporin A in male Wistar rats. International Journal of Pharmaceutics. 245(1-2). 143–151. 31 indexed citations

17.

Schleimer, Michael, et al.. (2000). Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. International Journal of Pharmaceutics. 211(1-2). 89–92. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact